Recent research indicates that treatment with Plasmodium chabaudi ASS infection and gemcitabine can block the CXCR2/TGF‐β‐mediated PI3K/Akt/GSK‐3β signaling pathway to inhibit EMT process of tumor cells.248. This evidence concerns the gene TGFB1 and neoplasm.